Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Stifel Financial Corp (SF)

Stifel Financial Corp (SF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 9,904,421
  • Shares Outstanding, K 102,456
  • Annual Sales, $ 4,349 M
  • Annual Income, $ 522,540 K
  • 60-Month Beta 1.09
  • Price/Sales 2.24
  • Price/Cash Flow 12.14
  • Price/Book 2.08
Trade SF with:

Options Overview Details

View History
  • Implied Volatility 28.83% ( +1.64%)
  • Historical Volatility 21.37%
  • IV Percentile 86%
  • IV Rank 62.63%
  • IV High 38.85% on 08/05/24
  • IV Low 12.03% on 08/22/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 484
  • Volume Avg (30-Day) 156
  • Put/Call OI Ratio 0.26
  • Today's Open Interest 3,606
  • Open Int (30-Day) 3,536

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate 1.65
  • Number of Estimates 1
  • High Estimate 1.65
  • Low Estimate 1.65
  • Prior Year 0.60
  • Growth Rate Est. (year over year) +175.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
81.28 +18.93%
on 09/11/24
97.24 -0.59%
on 10/09/24
+12.16 (+14.39%)
since 09/09/24
3-Month
76.64 +26.14%
on 08/05/24
97.24 -0.59%
on 10/09/24
+14.83 (+18.12%)
since 07/09/24
52-Week
54.81 +76.37%
on 10/25/23
97.24 -0.59%
on 10/09/24
+36.98 (+61.95%)
since 10/09/23

Most Recent Stories

More News
History Says the S&P 500 Could Soar: 2 Monster Stocks to Buy Now

These growth stocks will help you profit from the current bull market.

SHOP : 83.41 (+1.01%)
SF : 96.67 (+1.74%)
CRM : 287.92 (-1.25%)
Can Carnival Stock Cruise Higher Next Week?

The largest cruise line operator has a big earnings report to announce before the next opening bell.

SF : 96.67 (+1.74%)
CUK : 18.56 (+8.03%)
CCL : 20.20 (+7.05%)
MFG : 4.10 (-1.68%)
Why Penumbra Stock Zoomed Nearly 5% Higher Today

The company might just be the right kind of business operating at the right time in history.

SF : 96.67 (+1.74%)
PEN : 197.55 (+1.41%)
Why Relay Therapeutics Plummeted by Nearly 14% Today

Investors weren't happy with the company's latest effort at capital-raising.

GS : 505.18 (+1.73%)
BAC : 40.19 (+0.65%)
SF : 96.67 (+1.74%)
RLAY : 6.41 (+2.56%)
Here's Why Birkenstock Stock Dropped Nearly 16% Last Month

When valuations are high, even little things can lead to disappointment.

SF : 96.67 (+1.74%)
BIRK : 48.83 (+2.18%)
Are Wall Street Analysts Predicting Fastenal Stock Will Climb or Sink?

Fastenal has underperformed the broader market over the past year, and Wall Street analysts remain skeptical about the stock’s prospects.

FAST : 70.61 (+0.63%)
$SPX : 5,792.04 (+0.71%)
XLI : 136.69 (+0.89%)
SF : 96.67 (+1.74%)
Iovance Biotherapeutics Attracted a Downgrade. Is It Time to Sell?

Find out how concerned investors should be about setbacks for this company's revolutionary new cancer therapies.

MRK : 110.27 (+1.61%)
PIPR : 286.80 (-0.44%)
SF : 96.67 (+1.74%)
IOVA : 9.61 (-1.13%)
Stifel: Q2 Earnings Snapshot

Stifel: Q2 Earnings Snapshot

SF : 96.67 (+1.74%)
Stifel: Q1 Earnings Snapshot

Stifel: Q1 Earnings Snapshot

SF : 96.67 (+1.74%)
Why Summit Therapeutics Stock Crushed the Market This Week

The company was a standout in the biotech field, rising by nearly 23% over the period.

SF : 96.67 (+1.74%)
SMMT : 18.90 (-4.01%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

Stifel Financial Corp. is a holding company for Stifel Nicolaus & Company,Incorporated.

See More

Key Turning Points

3rd Resistance Point 99.17
2nd Resistance Point 98.20
1st Resistance Point 97.44
Last Price 96.67
1st Support Level 95.71
2nd Support Level 94.74
3rd Support Level 93.98

See More

52-Week High 97.24
Last Price 96.67
Fibonacci 61.8% 81.03
Fibonacci 50% 76.03
Fibonacci 38.2% 71.02
52-Week Low 54.81

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar